Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-3-31
pubmed:abstractText
To determine whether minimal residual disease (MRD) measured by Wilms' tumor gene 1 (WT1) expression is a prognostic marker in pediatric acute myeloid leukemia (AML), we quantified WT1 transcript by real-time quantitative-polymerase chain reaction in 92 AML at diagnosis and during follow-up.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1507-15
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16575000-Adolescent, pubmed-meshheading:16575000-Adult, pubmed-meshheading:16575000-Child, pubmed-meshheading:16575000-Child, Preschool, pubmed-meshheading:16575000-Core Binding Factor Alpha 2 Subunit, pubmed-meshheading:16575000-Female, pubmed-meshheading:16575000-Gene Dosage, pubmed-meshheading:16575000-Genes, Wilms Tumor, pubmed-meshheading:16575000-Humans, pubmed-meshheading:16575000-Infant, pubmed-meshheading:16575000-Infant, Newborn, pubmed-meshheading:16575000-Leukemia, Myeloid, Acute, pubmed-meshheading:16575000-Male, pubmed-meshheading:16575000-Multivariate Analysis, pubmed-meshheading:16575000-Neoplasm Proteins, pubmed-meshheading:16575000-Oncogene Proteins, Fusion, pubmed-meshheading:16575000-RNA, Messenger, pubmed-meshheading:16575000-Recurrence, pubmed-meshheading:16575000-Reverse Transcriptase Polymerase Chain Reaction
pubmed:year
2006
pubmed:articleTitle
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
pubmed:affiliation
Laboratoire d'hématologie, Service d'hématologie et d'oncologie pédiatrique, hôpital Trousseau, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't